CHP/PCOR Publications

Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase

Journal Article

Authors
AE Clarke
DP Goldman
Alan M. Garber - Stanford University

Published by
International Journal of Technology Assessment in Health Care, Vol. 8, page(s) 583-597
1992

Publications of interest

Benefits vs Profits: Has the Orphan Drug Act Gone Too Far?
Alan M. Garber
Pharmacoeconomics vol. 5 (1994)
Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease
Alan M. Garber, A.E. Clark, D.P. Goldman, M.E. Gluck
Washington, D.C.: U.S. Government Printing Office (1992)
Effects of Protease Inhibitors on the Spread of HIV and the Development of Drug-Resistant HIV Strains: A Simulation Study, The
GS Zaric, A Bayoumi, Margaret L. Brandeau, Douglas K. Owens
Simulation vol. 71 (1998)
Drug-eluting Stent Information Gap, The
Cynthia A. Yock, Paul Yock
American Heart Hospital Journal vol. 2 (2004)